The percentage of high expression MELK was, respectively, 8.33% (1/12) in CIN Grade I, 26.67% (4/15) in CIN Grade II, 44.44% (8/18) in CIN Grade III, and 56.92% (37/65) in cervical cancer patients (Figure 2B). Here, MELK is linked to cervical cancer.